Works matching IS 2574173X AND DT 2023 AND VI 43 AND IP 3
Results: 22
Preventive effect of aripiprazole once monthly on rehospitalization for bipolar disorder: A multicenter 1‐year retrospective mirror image study.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 425, doi. 10.1002/npr2.12371
- By:
- Publication type:
- Article
Differences in self‐reported psychotic symptoms between patients with autism spectrum disorder and those with schizophrenia.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 457, doi. 10.1002/npr2.12374
- By:
- Publication type:
- Article
Five‐year trend of antipsychotic prescription practices in a district Hospital in Ghana: A retrospective study.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 434, doi. 10.1002/npr2.12372
- By:
- Publication type:
- Article
Possible involvement of Interleukin‐17A in the deterioration of prepulse inhibition on acoustic startle response in mice.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 365, doi. 10.1002/npr2.12351
- By:
- Publication type:
- Article
Pain‐focused psychological interventions in women with endometriosis: A systematic review.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 310, doi. 10.1002/npr2.12348
- By:
- Publication type:
- Article
Association of two variable number of tandem repeats in the monoamine oxidase A gene promoter with suicide completion: The present study and meta‐analysis.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 338, doi. 10.1002/npr2.12344
- By:
- Publication type:
- Article
Inhibition of the dorsomedial striatal direct pathway is essential for the execution of action sequences.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 414, doi. 10.1002/npr2.12369
- By:
- Publication type:
- Article
Lipid‐correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophrenia.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 403, doi. 10.1002/npr2.12368
- By:
- Publication type:
- Article
Effects of age on suicide attempts by medication in patients transferred to the emergency rooms of two advanced medical centers: A retrospective chart review of the DJ project.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 453, doi. 10.1002/npr2.12367
- By:
- Publication type:
- Article
Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 391, doi. 10.1002/npr2.12366
- By:
- Publication type:
- Article
Japanese Society of Anxiety and Related Disorders/Japanese Society of Neuropsychopharmacology: Clinical practice guideline for social anxiety disorder (2021).
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 288, doi. 10.1002/npr2.12365
- By:
- Publication type:
- Article
Effects of riluzole on psychiatric disorders with anxiety or fear as primary symptoms: A systematic review.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 320, doi. 10.1002/npr2.12364
- By:
- Publication type:
- Article
Item response theory analysis of the University Personality Inventory in medical students.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 446, doi. 10.1002/npr2.12362
- By:
- Publication type:
- Article
Expression and role of nicotinic acetylcholine receptors during midbrain dopaminergic neuron differentiation from human induced pluripotent stem cells.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 440, doi. 10.1002/npr2.12361
- By:
- Publication type:
- Article
Effects of N‐acetylcysteine on oxidative stress biomarkers, depression, and anxiety symptoms in patients with multiple sclerosis.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 382, doi. 10.1002/npr2.12360
- By:
- Publication type:
- Article
Pharmacokinetics, safety, and tolerability of single and multiple doses of zuranolone in Japanese and White healthy subjects: A phase 1 clinical trial.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 346, doi. 10.1002/npr2.12359
- By:
- Publication type:
- Article
Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 359, doi. 10.1002/npr2.12358
- By:
- Publication type:
- Article
Longitudinal characteristics of insight and clinical factors in patients with schizophrenia.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 373, doi. 10.1002/npr2.12356
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 287, doi. 10.1002/npr2.12265
- Publication type:
- Article
Withdrawal: [Miura A, Otani K, Miyai H, Fukushima H, Matsuishi K. Post‐acute COVID‐19 syndrome with severe sexually deviant behavior. Neuropsychopharmacol Rep. 2022].
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 467, doi. 10.1002/npr2.12343
- Publication type:
- Article
Long‐term safety and efficacy of sublingual asenapine for the treatment of schizophrenia: A phase III extension study with follow‐up for 52 weeks (P06125)—Secondary publication.
- Published in:
- Neuropsychopharmacology Reports, 2023, v. 43, n. 3, p. 328, doi. 10.1002/npr2.12342
- By:
- Publication type:
- Article
Case reports of two siblings with autism spectrum disorder and 15q13.3 deletions.
- Published in:
- 2023
- By:
- Publication type:
- Case Study